Sort   by:  
 Page size 
UnknownSafety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study.
Not available
S-EPMC5559878 | biostudies-literature
UnknownVirtual facilitation best practices and research priorities: a scoping review.
Not available
S-EPMC10873989 | biostudies-literature
UnknownSleep and Alertness in a Duty-Hour Flexibility Trial in Internal Medicine.
Not available
S-EPMC6457111 | biostudies-literature
UnknownPatient Safety Outcomes under Flexible and Standard Resident Duty-Hour Rules.
Not available
S-EPMC6476299 | biostudies-literature
UnknownModulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors.
Not available
S-EPMC10720158 | biostudies-literature
UnknownThe National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment.
Not available
S-EPMC7454687 | biostudies-literature
UnknownIdentification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Not available
S-EPMC5612337 | biostudies-literature
UnknownIdentification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140 | biostudies-literature
UnknownStratified analyses refine association between TLR7 rare variants and severe COVID-19.
Not available
S-EPMC11320601 | biostudies-literature
UnknownGWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19.
Not available
S-EPMC10208981 | biostudies-literature
Sort   by:  
 Page size